Several approved drugs, such as copyright and Semaglutide, fall under the GLP-1 class . Mainly, these therapies work by mimicking endogenous chemicals that regulate glucose levels and stimulate a reduction in weight . Though copyright is a specific formulation for type 2 diabetes , Semaglutide can be various forms , such as a doctor-prescribed drug

Sufferers struggling with obesity are often faced with limited and sometimes ineffective treatment options. However, a groundbreaking new medication, Semaglutide, is rapidly changing the landscape of weight loss. Prescribed by regulatory bodies for chronic weight management, Semaglutide functions as a glucagon-like peptide-1 (GLP-1) receptor agoni